Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

11932 from 12462 pages
No results were found for the filter!
5-HT2A&5-HT2C agonist-1
5-HT2A&5-HT2C agonist-1

Item number: TGM-T79806-50mg

Description: 5-HT2A&5-HT2C agonist-1 (Example 2) is a dual-acting agent targeting 5-HT2A and 5-HT2C receptors with IC50 values of 196 nM and 0.9 nM, respectively. It is applicable in studying central nervous system disorders, including depression, alcoholism, tobacco and cocaine addiction, inflammation, cluster...
CAS 1640-02-4
MW: 232.32 D
Please request pricing for this article.
Review
JAK kinase-IN-1
JAK kinase-IN-1

Item number: TGM-T79807-50mg

Description: JAK kinase-IN-1 (Example 1) is a potent inhibitor targeting the JAK family, including TYK2, JAK1, JAK2, and JAK3, with IC50 values of 4.2 nM, 32 nM, 27 nM, and 3473 nM, respectively [1]. Target: JAK
CAS 2698389-43-2
MW: 407.44 D
Please request pricing for this article.
Review
KRAS G12C inhibitor 61
KRAS G12C inhibitor 61

Item number: TGM-T79808-50mg

Description: KRAS G12C inhibitor 61 (Example 3) demonstrates potent activity by inhibiting phospho-ERK 1/2 in MIA PaCa-2 cells, with an IC50 value of 9 nM, and is applicable in the research of pancreatic, colorectal, and lung cancers [1]. Target: ERK
Application: KRAS G12C inhibitor
CAS 2300967-40-0
MW: 590.09 D
Please request pricing for this article.
Review
ROCK-IN-8
ROCK-IN-8

Item number: TGM-T79809-50mg

Description: ROCK-IN-8 (Example 4), a ROCK inhibitor, exhibits anti-inflammatory properties and is suitable for respiratory and gastro-intestinal disease research, demonstrating an IC50 value below 100 nM [1]. Target: ROCK
CAS 1621103-79-4
MW: 556.61 D
Please request pricing for this article.
Review
Porcn-IN-2
Porcn-IN-2

Item number: TGM-T79810-50mg

Description: Porcn-IN-2 (Example 107) is a potent Wnt pathway inhibitor with an IC50 of 0.05 nM, applicable in cancer research including sarcoma, melanoma, skin cancer, hematological tumors, lymphoma, carcinoma, and leukemia [1]. Target: Others
CAS 1900754-65-5
MW: 462.43 D
Please request pricing for this article.
Review
DDR1/2 inhibitor-2
DDR1/2 inhibitor-2

Item number: TGM-T79811-50mg

Description: DDR1/2 Inhibitor-2 (Example 31) serves as an inhibitor of DDR1/DDR2, exhibiting IC50 values below 100 nM. It is applicable in cancer and fibrotic disease research [1]. Target: Others
Application: DDR1/2 inhibitor
CAS 2908756-11-4
MW: 492.45 D
Please request pricing for this article.
Review
Raf inhibitor 3
Raf inhibitor 3

Item number: TGM-T79813-50mg

Description: Raf inhibitor 3 (Example 30), a potent inhibitor of both B-Raf and C-Raf, exhibits IC50 values below 15 nM. It is applicable in cancer research studies [1]. Target: Raf
Application: Raf inhibitor
CAS 1662682-11-2
MW: 430.46 D
Please request pricing for this article.
Review
pan-KRAS-IN-3
pan-KRAS-IN-3

Item number: TGM-T79814-50mg

Description: Pan-KRAS-IN-3 (Example 84) is a pan-KRAS inhibitor suitable for cancer research [1]. Target: Ras
CAS 2875116-29-1
MW: 587.63 D
Please request pricing for this article.
Review
c-Fms-IN-14
c-Fms-IN-14

Item number: TGM-T79815-50mg

Description: c-Fms-IN-14 (Example 76) is a potent c-Fms kinase inhibitor with an IC50 of 4 nM, used in cancer and autoimmune disease research [1]. Target: c-Fms
CAS 1898210-99-5
MW: 436.51 D
Please request pricing for this article.
Review
S1P1 agonist 6 hemicalcium
S1P1 agonist 6 hemicalcium

Item number: TGM-T79817-50mg

Description: Compound I (S1P1 agonist 6 hemicalcium) is an S1P1 agonist that diminishes autoimmune activity by inhibiting lymphocyte trafficking, and serves as an immunosuppressive agent in researching a range of autoimmune diseases [1]. Target: LPL Receptor
CAS 2941310-03-6
MW: 465.51 D
Please request pricing for this article.
Review
PROTAC BRD4 Degrader-21
PROTAC BRD4 Degrader-21

Item number: TGM-T79818-50mg

Description: PROTAC BRD4 Degrader-21 (Comp 74), a potent BRD4 degrader, has shown significant inhibition of tumor growth in mouse xenograft models, indicating its potential for anticancer research [1]. Target: Epigenetic Reader Domain
CAS 2503036-46-0
MW: 925.97 D
Please request pricing for this article.
Review
AMB639752
AMB639752

Item number: TGM-T79819-50mg

Description: AMB639752 is a potent inhibitor of diacylglycerol kinase alpha (DGKalpha) that reinstates restimulation-induced cell death (RICD) in SAP-deficient lymphocytes through DGKalpha inhibition within intact cells. This compound is applicable in the research of X-linked lymphoproliferative disease 1 (XLP-1)...
CAS 371210-26-3
MW: 365.43 D
Please request pricing for this article.
Review
11932 from 12462 pages